Peter Mrak

406 total citations
12 papers, 330 citations indexed

About

Peter Mrak is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Peter Mrak has authored 12 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pharmacology and 3 papers in Genetics. Recurrent topics in Peter Mrak's work include Microbial Natural Products and Biosynthesis (7 papers), Biochemical and Molecular Research (3 papers) and Genomics and Phylogenetic Studies (3 papers). Peter Mrak is often cited by papers focused on Microbial Natural Products and Biosynthesis (7 papers), Biochemical and Molecular Research (3 papers) and Genomics and Phylogenetic Studies (3 papers). Peter Mrak collaborates with scholars based in Slovenia, United States and Switzerland. Peter Mrak's co-authors include Gregor Kopitar, Darja Žgur‐Bertok, Zdravko Podlesek, Štefan Fujs, Gregor Kosec, Dušan Goranovič, Hrvoje Petković, Janez Mulec, Jos P. M. van Putten and Alojz Ihan and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Peter Mrak

12 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Mrak Slovenia 9 267 120 68 41 40 12 330
Ekaterina S. Komarova Russia 14 334 1.3× 106 0.9× 94 1.4× 22 0.5× 65 1.6× 26 475
C. Leigh Allen United States 9 262 1.0× 175 1.5× 27 0.4× 35 0.9× 14 0.3× 11 340
Iris Thamm Belgium 10 205 0.8× 57 0.5× 57 0.8× 33 0.8× 24 0.6× 13 397
Jürgen Felsberg Czechia 12 204 0.8× 61 0.5× 21 0.3× 35 0.9× 21 0.5× 29 322
Rachel M. Bleich United States 9 286 1.1× 48 0.4× 38 0.6× 24 0.6× 53 1.3× 14 383
Karel Mikulı́k Czechia 13 298 1.1× 117 1.0× 69 1.0× 11 0.3× 55 1.4× 32 377
Billyana Tsvetanova United States 6 172 0.6× 60 0.5× 59 0.9× 21 0.5× 35 0.9× 8 241
Brian V. Falcone United States 4 264 1.0× 50 0.4× 89 1.3× 32 0.8× 33 0.8× 6 339
Pablo E. Tomatis Argentina 11 229 0.9× 106 0.9× 103 1.5× 14 0.3× 17 0.4× 15 467
J. Andrew N. Alexander Canada 9 148 0.6× 55 0.5× 45 0.7× 22 0.5× 20 0.5× 14 309

Countries citing papers authored by Peter Mrak

Since Specialization
Citations

This map shows the geographic impact of Peter Mrak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mrak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mrak more than expected).

Fields of papers citing papers by Peter Mrak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Mrak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mrak. The network helps show where Peter Mrak may publish in the future.

Co-authorship network of co-authors of Peter Mrak

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Mrak. A scholar is included among the top collaborators of Peter Mrak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Mrak. Peter Mrak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Avbelj, Martina, Martin Šala, Paul Herron, et al.. (2024). Oxytetracycline hyper-production through targeted genome reduction of Streptomyces rimosus. mSystems. 9(5). e0025024–e0025024. 5 indexed citations
2.
Buntin, Kathrin, Peter Mrak, Philipp Krastel, et al.. (2023). Generation of Bioactivity‐Tailored FK506/FK520 Analogs by CRISPR Editing in Streptomyces tsukubaensis. Chemistry - A European Journal. 30(3). e202302350–e202302350. 2 indexed citations
3.
Bruccoleri, Robert E., et al.. (2022). Teleocidin-producing genotype of Streptomyces clavuligerus ATCC 27064. Applied Microbiology and Biotechnology. 106(4). 1521–1530. 2 indexed citations
4.
Mrak, Peter, et al.. (2018). Discovery of the actinoplanic acid pathway in Streptomyces rapamycinicus reveals a genetically conserved synergism with rapamycin. Journal of Biological Chemistry. 293(52). 19982–19995. 18 indexed citations
6.
7.
Goranovič, Dušan, Tomaž Polak, Javier Santos‐Aberturas, et al.. (2012). FK506 biosynthesis is regulated by two positive regulatory elements in Streptomyces tsukubaensis. BMC Microbiology. 12(1). 238–238. 50 indexed citations
8.
Kosec, Gregor, Dušan Goranovič, Peter Mrak, et al.. (2011). Novel chemobiosynthetic approach for exclusive production of FK506. Metabolic Engineering. 14(1). 39–46. 37 indexed citations
9.
Goranovič, Dušan, Gregor Kosec, Peter Mrak, et al.. (2010). Origin of the Allyl Group in FK506 Biosynthesis. Journal of Biological Chemistry. 285(19). 14292–14300. 69 indexed citations
10.
Mrak, Peter, Zdravko Podlesek, Jos P. M. van Putten, & Darja Žgur‐Bertok. (2007). Heterogeneity in expression of the Escherichia coli colicin K activity gene cka is controlled by the SOS system and stochastic factors. Molecular Genetics and Genomics. 277(4). 391–401. 29 indexed citations
11.
Rijavec, Matija, et al.. (2006). Prevalence of ColE1-Like Plasmids and Colicin K Production among Uropathogenic Escherichia coli Strains and Quantification of Inhibitory Activity of Colicin K. Applied and Environmental Microbiology. 73(3). 1029–1032. 21 indexed citations
12.
Mulec, Janez, Zdravko Podlesek, Peter Mrak, et al.. (2003). A cka-gfp Transcriptional Fusion Reveals that the Colicin K Activity Gene Is Induced in Only 3 Percent of the Population. Journal of Bacteriology. 185(2). 654–659. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026